Research Article

Acute Pancreatitis in Pregnancy: A Ten-Year Noninterventional, Retrospective Cohort Experience

Table 3

Association between disease severity, clinical parameters, and pregnant outcomes.

(%) or mean (S.D.)MAPMSAPSAP value

Pregnancy outcome0.2001
Caesarean section8 (42.11)6 (40)6 (54.55)
Continued pregnancy9 (47.37)5 (33.33)1 (9.09)
Induced labor1 (5.26)3 (20)2 (18.18)
Natural birth1 (5.26)0 (0)0 (0)
Stillbirth0 (0)1 (6.67)2 (18.18)
Presence of complication#0.01729
Yes11 (57.89)13 (86.67)11 (100)
No8 (42.11)2 (13.33)0 (0)
Gestational weeks
13 to 287 (36.84)6 (40)3 (27.27)0.8535
29 to4012 (63.16)9 (60)8 (72.73)
BMI (kg/m2)26.79 (3.81)25.85 (2.71)27.61 (3.37)0.42
Blood amylase levels (IU/L)
<2005 (26.32)9 (60)4 (40)0.2844
200 to 5003 (15.79)1 (6.67)3 (30)
501 to 8005 (26.32)2 (13.33)0 (0)
>8016 (31.58)3 (20)3 (30)
Lipase levels (IU/L)
<2009 (50)7 (46.67)3 (33.33)0.6094
200 to 5003 (16.67)2 (13.33)2 (22.22)
501 to 8000 (0)2 (13.33)2 (22.22)
>8016 (33.33)4 (26.67)2 (22.22)
Triglyceride levels (mmol/L)
<58 (47.06)7 (50)2 (18.18)0.08957
5 to 208 (47.06)6 (42.86)4 (36.36)
>211 (5.88)1 (7.14)5 (45.45)

#Complications included choledocholithiasis, chronic hepatitis B, diabetes, hypertriglyceridemia, severe eclampsia, pulmonary infection, fatty liver, ketoacidosis, gallstones, HELLP syndrome, placenta previa, and gestational diabetes. MAP: mild acute pancreatitis; MSAP: moderately severe acute pancreatitis; SAP: severe acute pancreatitis.